Connect with us

Health

Why Santa May Have Originally Been a Eurasian Shaman Who Used Psychedelic Mushrooms

Published

on

In Brief

  • The Facts:

    The origin of "Santa Claus" might have something to do with psychedelic mushrooms if we look at interpretations that pre date Christianity.

  • Reflect On:

    Santa today has become a figure that's used for massive amounts of profit. Is Christmas really about giving? Or is 'giving' simply used to sell a number of products? Christmas should have nothing to do with buying anything, or should it?

CE by no means promotes eating wild amanita muscaria, at all.

advertisement - learn more

As a child, the Christmas season always represented great things. The holiday cheer, the familial celebrations, and most exciting of all, presents. But as I grew into adulthood, the sparkling veil of the Christmas season soon revealed it’s true form – a religious-based, commercial lie meant to perpetuate consumerism and materialism.

I eventually let go of my jaded view of Christmas, and created my own meaning for the holiday season, which now saw the end of the year as a dedicated time to spend with the ones I love, and to reflect on the experiences and lessons of the previous year. Not that Christmas is the only time to do this, but let’s face it, life has a tendency to otherwise keep us preoccupied.

But recently my views on Christmas were challenged once again, after reading up on the pre-Christian history of Santa Claus and his ‘magical’ reindeer. I was shocked to hear a proposed theory of the story’s origins, which explained how Santa may have originally been a northern Eurasian shaman who used the psychedelic mushroom amanita muscaria, and that many of the well known Christmas symbols, such as the tree, the star, and the gifts, were actually inspired by esoteric practices involving the red and white magic mushroom.

A Siberian Shaman With A Bag Of Special ‘Gifts’

ShamanClaus

Could the story of Santa actually be inspired by Shamanistic practices out of Northern Europe and Asia during the pre-Christian era?

In his articleMagic Mushrooms May Explain Santa & His ‘Flying’ Reindeer, author Douglas Main explains how the story of Santa and his flying reindeer can be traced to an unlikely source: hallucinogenic or “magic” mushrooms. Speaking with John Rush, an anthropologist and instructor at Sierra College in Rocklin, California, Main learned more about Santa’s story.

“Santa is a modern counterpart of a shaman, who consumed mind-altering plants and fungi to commune with the spirit world,” said Rush.

advertisement - learn more

According to the theory, the legend of Santa derives from shamans in the Siberian and Arctic regions who dropped into locals’ teepee-like homes with a bag full of hallucinatory mushrooms as presents in late December.

As the story goes, up until a few hundred years ago these practicing shamans or priests connected to the older traditions would collect Amanita muscaria (the Holy Mushroom), dry them, and then give them as gifts on the winter solstice,” Rush told LiveScience. “Because snow is usually blocking doors, there was an opening in the roof through which people entered and exited, thus the chimney story.”

The Christmas Tree Connection

In his book, Mushrooms and Mankindlate author James Arthur points out that amanita muscaria, also known as fly agaric, lives throughout the Northern Hemisphere under conifers and birch trees, with which the fungi —which is deep red with white flecks — has a symbiotic relationship. This partially explains the practice of the Christmas tree, and the placement of bright red-and-white presents underneath, which look like Amanita mushrooms, he wrote.

From Northern Antiquities, an English translation of the Prose Edda from 1847. Painted by Oluf Olufsen Bagge.

Was the Christmas tree tradition based off of ancient Northern European symbology? Painted by Oluf Olufsen Bagge.

Why do people bring pine trees into their houses at the Winter Solstice, placing brightly colored (red and white) packages under their boughs, as gifts to show their love for each other … ?” he wrote. “It is because, underneath the pine bough is the exact location where one would find this ‘Most Sacred’ substance, the Amanita muscaria, in the wild.”

Author Dana Larsen elaborated on the pre-Christian symbology of the Christmas tree in her article, The Psychedelic Secrets of Santa. She explains how the ancient northern European people, including the Lapps of modern-day Finland, and the Koyak tribes of the central Russian steppes, believed in the idea of a World Tree. The World Tree was seen as a kind of cosmic axis, onto which the planes of the universe are fixed. The roots of the World Tree stretch down into the underworld, its trunk is the “middle earth” of everyday existence, and its branches reach upwards into the heavenly realm.

The North Star was also considered sacred, since all other stars in the sky revolved around its fixed point. They associated this “Pole Star” with the World Tree and the central axis of the universe. The top of the World Tree touched the North Star, and the spirit of the shaman would climb the metaphorical tree, thereby passing into the realm of the gods” wrote Larsen.

“So Up To The House-Top The Coursers They Flew”: Breaking Down The ‘Flying’ Reindeer

Perhaps one of the most memorable aspects of Santa Claus mythology are his co-pilot counterparts, his flying reindeer.

Reindeer are rampant in Siberia, and are also known to include various fungi in their diet, as seen in the BBC Weird Nature video below.

Donald Pfister, a biologist who studies fungi at Harvard University, suggests that Siberian tribesmen who ingested fly agaric (amanita muscaria) may have hallucinated into thinking that reindeer were flying.

At first glance, one thinks it’s ridiculous, but it’s not,” said Carl Ruck, a professor of classics at Boston University. “Whoever heard of reindeer flying? I think it’s becoming general knowledge that Santa is taking a ‘trip’ with his reindeer,” Ruck said.

Controversy Over Linking The Pre-Christian Santa To The Modern Day Version of St. Nick

As convincing as the theory may be, many historians and anthropologists disagree with the Amanita shamanic version of Santa Claus, and claim that our current depiction of the jolly old man has in fact evolved from a 4th century Greek-Christian bishop named Saint Nicholas, who was known for his generous gifts to the poor.

Then, in 1823, a New York City aristocratic academic by the name of Clement Clarke Moore wrote the infamous poem, “A Visit From St. Nicholas” (which later became “Twas The Night Before Christmas“), which was thought to have been inspired by the Christian bishop, and which envisioned an entirely new portrayal of St. Nick.  Throughout the next few centuries, the image of Santa Claus became ubiquitous throughout Western culture, and was re-sculpted and refined by clever marketing organizations such as Coca Cola. Hence the fat, bearded character we know today.

But Germanic folklore tells an even different story of the true origins of Santa Claus. Prior to Christianization, the Germanic peoples celebrated a midwinter event called Yule. With the Christianization of Germanic Europe, numerous traditions were absorbed from Yuletide celebrations into modern Christmas. During this period, supernatural and ghostly occurrences were said to increase in frequency, such as the Wild Hunt, a ghostly procession through the sky. The leader of the wild hunt is frequently attested as the god Odin, who bears the Old Norse names Jólnir, meaning “yule figure” and the name Langbarðr, meaning “long-beard.”

In this later 1881 illustration by Thomas Nast named “Merry Old Santa” the modern Santa character really begins to take shape. Present is the jolly rotundity and the all important red of the suit.

James Arthur wrote that at the very least, Santa’s sleigh and reindeer are references back to various related Northern European mythology. For example, the Norse god Thor (known in German as “Donner”) flew in a chariot drawn by two goats, which have been replaced in the modern retelling by Santa’s reindeer.

So Where Does Santa Really Come From?

The true origins of the pre-Christian Santa are convoluted to say the least, however, one can only consider that the version we see of Santa today is a conglomerate of folklore and mythology from multiple Eurasian cultures of the past. Therein lies the issue of tracing Santa’s true beginnings.

That being said, investigating Santa’s past is amusing at the very least, and I think the shamanic version of the story stands as the most fascinating of all. What are your thoughts on the origins of Santa and his reindeer? Do you think the Amanita muscaria legend could be true?

The Takeaway

Ultimately, the real origins regarding the story of Santa may be virtually untraceable, but it’s interesting to look at just how many versions of the story there are. Today, society has drifted far from any real meaning during Christmas, as it seems to have become a time of mass marketing, extreme buying, and nothing but gift giving. That being said, every year at this time we are reminded that giving is receiving, and service to others is what really fulfills us and makes us happy on the inside. Let us feel this way, everyday, and strive to live our lives recognizing that we are one part of a massive whole, and we’re all in this together.

Changing the world starts with you, with your life, how you treat others and overall just being a ‘good person.’ Our human experience today is one where many are still suffering needlessly, there is much we need to change about our planet and Christmas time is a great reminder for everybody that it’s great to think about others. This shouldn’t be practiced once a year, but every single day. To be perfectly honest, Christmas should have nothing to do with presents.

Help Support Collective Evolution

The demand for Collective Evolution's content is bigger than ever, except ad agencies and social media keep cutting our revenues. This is making it hard for us to continue.

In order to stay truly independent, we need your help. We are not going to put up paywalls on this website, as we want to get our info out far and wide. For as little as $3 a month, you can help keep CE alive!

SUPPORT CE HERE!

cards

Advertisement
advertisement - learn more

Health

The Powerful Aspirin Alternative Your Doctor Never Told You About

Published

on

In Brief

  • The Facts:

    This article was written by Sayer Ji, Founder of Greenmedinfo,com where it was originally posted. Published here with permission.

  • Reflect On:

    Given the newly released cardiovascular disease prevention guidelines recommending against daily low-dose aspirin use, natural, safe and effective alternatives are needed now more than ever.

In a previous article titled “The Evidence Against Aspirin and For Natural Alternatives,” we discussed the clear and present danger linked with the use of aspirin as well as several clinically proven alternatives that feature significant side benefits as opposed to aspirin’s many known side effects.

Since writing this article, even more evidence has accumulated indicating that aspirin’s risks outweigh its benefits. Most notably, a 15-year Dutch study published in the journal Heart found that among 27,939 healthy female health professionals (average age 54) randomized to receive either 100 mg of aspirin every day or a placebo the risk of gastrointestinal bleeding outweighed the benefit of the intervention for colorectal cancer and cardiovascular disease prevention in those under 65 years of age. Most recently, last month, new cardiovascular disease prevention guidelines submitted jointly by the American College of Cardiology and the American Heart Associated and published in the Journal of the American College of Cardiology, earlier this year, contradict decades of routine medical advice by explicitly advising against the daily use of low-dose or baby aspirin (75-100 mg) as a preventive health strategy against stroke or heart attack, in most cases.

Of course, aspirin is not alone as far as dangerous side effects are concerned. The entire non-steroidal anti-inflammatory (NSAID) category of prescription and over-the-counter drugs is fraught with serious danger. Ibuprofen, for instance, is known to kill thousands each year, and is believed no less dangerous than Merck’s COX-2 inhibitor NSAID drug Vioxx which caused between 88,000-140,000 cases of serious heart disease in the five years it was on the market (1999-2004). Tylenol is so profoundly toxic to the liver that contributing writer Dr. Michael Murray recently asked in his Op-Ed piece, “Is it Time for the FDA to Remove Tylenol From the Market?” Just as serious are tylenol’s empathy destroying properties that were only identified four years ago.

Given the dire state of affairs associated with pharmaceutical intervention for chronic pain issues, what can folks do who don’t want to kill themselves along with their pain?

Pine Bark Extract (Pycnogenol) Puts Aspirin To Shame

When it comes to aspirin alternatives, one promising contender is pycnogenol, a powerful antioxidant extracted from French maritime pine bark, backed by over 40 years of research, the most compelling of which we have aggregated on GreenMedInfo.com here: Pycnogenol Research. Amazingly, you will find research indexed there showing it may have value for over 80 health conditions.

advertisement - learn more

In 1999, a remarkable study published in the journal Thrombotic Research found that pycnogenol was superior (i.e. effective at a lower dosage) to aspirin at inhibiting smoking-induced clotting, without the significant (and potentially life-threatening) increase in bleeding time associated with aspirin use. The abstract is well worth reading in its entirety:

“The effects of a bioflavonoid mixture, Pycnogenol, were assessed on platelet function in humans. Cigarette smoking increased heart rate and blood pressure. These increases were not influenced by oral consumption of Pycnogenol or Aspirin just before smoking. However, increased platelet reactivity yielding aggregation 2 hours after smoking was prevented by 500 mg Aspirin or 100 mg Pycnogenol in 22 German heavy smokers. In a group of 16 American smokers, blood pressure increased after smoking. It was unchanged after intake of 500 mg Aspirin or 125 mg Pycnogenol. In another group of 19 American smokers, increased platelet aggregation was more significantly reduced by 200 than either 150 mg or 100 mg Pycnogenol supplementation. This study showed that a single, high dose, 200 mg Pycnogenol, remained effective for over 6 days against smoking-induced platelet aggregation. Smoking increased platelet aggregation that was prevented after administration of 500 mg Aspirin and 125 mg Pycnogenol. Thus, smoking-induced enhanced platelet aggregation was inhibited by 500 mg Aspirin as well as by a lower range of 100-125 mg Pycnogenol. Aspirin significantly (p<0.001) increased bleeding time from 167 to 236 seconds while Pycnogenol did not. These observations suggest an advantageous risk-benefit ratio for Pycnogenol.” [emphasis added]

As emphasized in bold above, pycnogenol unlike aspirin did not significantly increase bleeding time. This has profound implications, as aspirin’s potent anti-platelet/’blood thinning’ properties can also cause life-threatening hemorrhagic events. If this study is accurate and pycnogenol is more effective at decreasing pathologic platelet aggregation at a lower dose without causing the increased bleeding linked to aspirin, then it is clearly a superior natural alternative worthy of far more attention by the conventional medical establishment and research community than it presently receives.

Not Just A Drug Alternative

Pycnogenol, like so many other natural interventions, has a wide range of side benefits that may confer significant advantage when it comes to reducing cardiovascular disease risk. For instance, pycnogenol is also:

  • Blood Pressure Reducing/Endothelial Function Enhancer: A number of clinical studies indicate that pycnogenol is therapeutic for those suffering with hypertension. Pycnogenol actually addresses a root cause of hypertension and cardiovascular disease in general, namely, endothelial dysfunction (the inability of the inner lining of the blood vessels to function correctly, e.g. fully dilate).[1] It has been shown to prevent damage in microcirculation in hypertensive patients, as well as reducing the dose of blood pressure drugs in hypertensive patients,[2]including hypertensive diabetic patients.[3] It has even been found to reduce intraocular hypertension found in glaucoma patients.[4]
  • Anti-Inflammatory Effects: There is a growing appreciation among the medical community that inflammation contributes to cardiovascular disease. Several markers, including C-reactive protein are now being fore grounded as being at least as important in determining cardiovascular disease risk as various blood lipids and/or their ratios, such as low-density lipoprotein (LDL). Pycnogenol has been found to reduce C-reactive protein in hypertensive patients.[5] Pycnogenol has been found to rapidly modulate downward (inhibit) both Cox-1 and Cox-2 enzyme activity in human subjects, resulting in reduced expression of these inflammation-promoting enzymes within 30 minutes post-ingestion.[6] Another observed anti-inflammatory effect of pycnogenol is its ability to down-regulate the class of inflammatory enzymes known as matrix metalloproteinases (MMPs).[7] Pycnogenol has also been found to significantly inhibit NF-kappaB activation, a key body-wide regulator of inflammation levels whose overexpression and/or dysregulation may result in pathologic cardiovascular manifestations.[8] Finally, pycnogenol has been found to reduce fibrinogen levels, a glycoprotein that contributes to the formation of blood clots; fibrinogen has been identified as an independent risk factor for cardiovascular disease.[9]
  • The Ideal Air Travel Companion: In a previous article entitled, “How Pine Bark Extract Could Save Air Travelers Lives,” we delve into a compelling body of research that indicates pycnogenol may be the perfect preventive remedy for preventing flight-associated thrombosis, edema, and concerns related to radiotoxicity and immune suppression.

Given the evidence for pycnogenol’s pleotrophic cardioprotective properties, we hope that pycnogenol will become more commonly recommended by health care practitioners as the medical paradigm continues to evolve past its reliance on synthetic chemicals, eventually (we hope) returning to natural, increasingly evidence-based interventions. However, it is important that we don’t fall prey to the one-disease-one-pill model, convincing ourselves to focus on popping pills – this time natural ones – as simply countermeasures or ‘insurance’ against the well-known harms associated with the standard American diet, lack of exercise and uncontrolled stress. The ultimate goal is to remove the need for pills altogether, focusing on preventing cardiovascular disease from the ground up and inside out, e.g. letting high quality food, clean water and air, and a healthy attitude nourish and sustain your health and well-being.


References

[1] Ximing Liu, Junping Wei, Fengsen Tan, Shengming Zhou, Gudrun Würthwein, Peter Rohdewald. Pycnogenol, French maritime pine bark extract, improves endothelial function of hypertensive patients. Life Sci. 2004 Jan 2;74(7):855-62. PMID: 14659974

[2] Gianni Belcaro, Maria Rosaria Cesarone, Andrea Ricci, Umberto Cornelli, Peter Rodhewald, Andrea Ledda, Andrea Di Renzo, Stefano Stuard, Marisa Cacchio, Giulia Vinciguerra, Giuseppe Gizzi, Luciano Pellegrini, Mark Dugall, Filiberto Fano. Control of edema in hypertensive subjects treated with calcium antagonist (nifedipine) or angiotensin-converting enzyme inhibitors with Pycnogenol. Clin Appl Thromb Hemost. 2006 Oct;12(4):440-4. PMID: 17000888

[3] Sherma Zibadi, Peter J Rohdewald, Danna Park, Ronald Ross Watson. Reduction of cardiovascular risk factors in subjects with type 2 diabetes by Pycnogenol supplementation. Nutr Res. 2008 May;28(5):315-20. PMID: 19083426

[4] Robert D Steigerwalt, Belcaro Gianni, Morazzoni Paolo, Ezio Bombardelli, Carolina Burki, Frank Schönlau. Effects of Mirtogenol on ocular blood flow and intraocular hypertension in asymptomatic subjects. Mol Vis. 2008;14:1288-92. Epub 2008 Jul 10. PMID: 18618008

[5] Maria Rosaria Cesarone, Gianni Belcaro, Stefano Stuard, Frank Schönlau, Andrea Di Renzo, Maria Giovanna Grossi, Mark Dugall, Umberto Cornelli, Marisa Cacchio, Giuseppe Gizzi, Luciano Pellegrini. Kidney flow and function in hypertension: protective effects of pycnogenol in hypertensive participants–a controlled study. J Cardiovasc Pharmacol Ther. 2010 Mar;15(1):41-6. Epub 2010 Jan 22. PMID: 20097689

[6] Angelika Schäfer, Zuzana Chovanová, Jana Muchová, Katarína Sumegová, Anna Liptáková, Zdenka Duracková, Petra Högger. Inhibition of COX-1 and COX-2 activity by plasma of human volunteers after ingestion of French maritime pine bark extract (Pycnogenol). Biomed Pharmacother. 2006 Jan;60(1):5-9. Epub 2005 Oct 26. PMID: 16330178

[7] Tanja Grimm, Angelika Schäfer, Petra Högger. Antioxidant activity and inhibition of matrix metalloproteinases by metabolites of maritime pine bark extract (pycnogenol). Wei Sheng Yan Jiu. 2011 Jan;40(1):103-6. PMID: 14990359

[8] Tanja Grimm, Zuzana Chovanová, Jana Muchová, Katarína Sumegová, Anna Liptáková, Zdenka Duracková, Petra Högger. Inhibition of NF-kappaB activation and MMP-9 secretion by plasma of human volunteers after ingestion of maritime pine bark extract (Pycnogenol). J Inflamm (Lond). 2006;3:1. Epub 2006 Jan 27. PMID: 16441890

[9] G Belcaro, M R Cesarone, S Errichi, C Zulli, B M Errichi, G Vinciguerra, A Ledda, A Di Renzo, S Stuard, M Dugall, L Pellegrini, G Gizzi, E Ippolito, A Ricci, M Cacchio, G Cipollone, I Ruffini, F Fano, M Hosoi, P Rohdewald. Variations in C-reactive protein, plasma free radicals and fibrinogen values in patients with osteoarthritis treated with Pycnogenol. Redox Rep. 2008;13(6):271-6. PMID: 19017467

Originally published: 2017-07-23

Article updated: 2019-04-11


Link to original article


Greenmedinfo Newsletter

Help Support Collective Evolution

The demand for Collective Evolution's content is bigger than ever, except ad agencies and social media keep cutting our revenues. This is making it hard for us to continue.

In order to stay truly independent, we need your help. We are not going to put up paywalls on this website, as we want to get our info out far and wide. For as little as $3 a month, you can help keep CE alive!

SUPPORT CE HERE!

cards

Continue Reading

Awareness

Long-Term Consequences of Mumps Vaccination: Many Unanswered Questions

Published

on

This is Part II of a two-part series on mumps. Part I discussed how mumps vaccination and the flawed mumps component of Merck’s MMR vaccine are fostering dangerous mumps outbreaks in adolescents and young adults.

It has been about five decades since the U.S. Food and Drug Administration (FDA) approved Merck’s first mumps vaccine. The company began launching combination MMR (measles, mumps and rubella) vaccines in the 1970s. Coincidentally—or not—an infertility crisis has been brewing over roughly the same time period, with dramatic declines in sperm counts and record-lowfertility levels. However, few investigators seem interested in assessing whether mumps outbreaks in highly vaccinated populations of teens and young adults could be having long-termeffects on fertility or other health indicators.

As described in Part I, childhood MMR vaccination has been an unmitigated disaster where mumps is concerned, deferring mumps infection to older ages and leaving adolescents and young adults vulnerable to serious reproductive complications. Public health reports show that the vast majority of mumps cases and outbreaks occur in youth who have been fully vaccinatedwith the prescribed two-dose MMR series, supporting a hypothesis of “waning immunity after the second dose.” FDA and Centers for Disease Control and Prevention (CDC) officials even admitthat mumps outbreaks in the post-vaccination era “typically involve young adults,” and that vaccination is failing to protect those who are college-age and above.

Myopically, many vaccine experts have called for a third MMR dose—or even “booster dosing throughout adulthood”—even though the FDA’s and CDC’s own research shows that MMR boosters in college-age youth barely last one year. As alleged in whistleblower lawsuits wending their way through the courts over the past eight years, Merck presented the FDA with a “falsely inflated efficacy rate” for the MMR’s mumps component, using animal antibodies and other fraudulent tactics to fool FDA—and the public—into believing that the vaccine was effective.

When infection arises after puberty, however, mumps is no laughing matter, presenting an increased risk of complications such as hearing loss, encephalitis and inflammation of the reproductive organs.

Mumps after puberty is no laughing matter

Around the time that the first mumps vaccine came on the market, the 1967 children’s classic The Great Brain humorously depicted mumps infection in childhood as a mere nuisance. The book’s young protagonist goes out of his way to intentionally infect himself with mumps so that he can beat his two brothers to the recovery finish line—and he experiences no adverse consequences other than his siblings’ annoyance.

advertisement - learn more

When infection arises after puberty, however, mumps is no laughing matter, presenting an increased risk of complications such as hearing loss, encephalitis and inflammation of the reproductive organs. About one in three postpubertal men with mumps develops orchitis(inflammation of the testes), which can damage sperm, affect testosterone production and contribute to subfertility and infertility. During a mumps outbreak in England in the mid-2000s, mumps orchitis accounted for 42% of all hospitalized mumps cases; the researchers attributed this outcome—which was the most common reason for hospitalization—to “the high attack rates in adolescents and young adults” that occurred “despite high coverage with two-dose MMR.” An analysis of a 2006 mumps outbreak in the U.S. reported that male patients were over three times more likely than female patients to experience complications, “due primarily to orchitis.”

An estimated 5% to 10% of postpubertal women will develop oophoritis (swelling of the ovaries) following mumps infection. Oophoritis is associated with premature menopause and infertility, but mumps-related oophoritis has garnered little notice.

Mumps infections are often asymptomatic or produce nonspecific symptoms such as fever, while cases of orchitis may present with no other mumps symptoms. Nonetheless, public health officials advise clinicians that orchitis is an instant cue to test for mumps virus, and testing often reveals elevated mumps antibodies. In a case report of MMR failure, British clinicians isolated a novel genetic strain of mumps virus from the patient’s semen two weeks after the onset of orchitis and found mumps RNA in the semen 40 days later; they also noted “the appearance of anti-sperm antibodies,” with “potential long-term adverse effects on the patient’s fertility.”

In 2017, researchers who reviewed 185 studies conducted in Western nations found that sperm counts had plummeted by 50% to 60% between 1973 and 2011—an average decrease of 1.4% annually. Commenting on this work, one analyst estimated that 20% to 30% of young men in Europe and North America have sperm concentrations associated with a reduced ability to father a child. Given estimates that as much as 40% of reproductive problems have to do with the male partner, there is agreement on the importance of “finding and eliminating [the] hidden culprits in the environment” that most researchers believe are to blame.

An estimated 5% to 10% of postpubertal women will develop oophoritis (swelling of the ovaries) following mumps infection. Oophoritis is associated with premature menopause and infertility, but mumps-related oophoritis has garnered little notice.

MMR’s and MMRV’s potential to impair fertility never studied

Merck has not evaluated either of its two MMR vaccines—the MMR-II and the MMR-plus-varicella (MMRV) vaccine—for their potential to impair fertility. Whether such testing would unearth direct effects on fertility (as appears to be possible with HPV vaccination in women) is thus unknown. However, mumps vaccination undeniably increases reproductive-age individuals’ risk of mumps infection and, in the process, increases the risk of fertility-altering complications. These facts alone should be attracting far more attention.

Unfortunately, because clinicians already tend to underdiagnose mumps infection and underestimate mumps complications, it is likely that they are failing to recognize possible vaccine-induced reproductive health consequences of mumps infection in their adolescent and young adult patients. In one university outbreak, “most physicians…did not suspect mumps,” and even when they became aware of the outbreak, “diagnosing mumps was not always straightforward.” Moreover, although differentiating between vaccine strains of mumps virus and wild types could provide valuable information, few clinicians have the capacity or inclination to perform testing of this type. A Japanese study of cerebrospinal fluid and saliva from patients with mumps complications found vaccine strain in nearly all of the samples and noted the information’s importance in helping determine whether the complications were vaccine-related.

Those who have sought to understand mumps vaccines’ poor performance point to a mixture of explanatory factors. These include waning immunity, the high population density and close quarters encountered in settings such as college campuses, incomplete vaccine-induced immunity to wild virus as well as viral evolution such that “the vaccine triggers a less potent reaction against today’s mumps viruses than those of 50 years ago.” However, some also quietly admit that individuals with “mild vaccine-modified disease” could be perpetuating the chain of transmission. This latter point ought to be raising questions about the logic and wisdom of administering further rounds of MMR boosters during outbreaks while ignoring the problems created by the doses already given.

… some individuals respond poorly to mumps vaccination and vaccine-induced antibody levels correlate poorly with protection from mumps infection, irrespective of the number of additional doses of mumps-containing vaccine they receive.

Most scientists appear to be either resigned to ongoing mumps outbreaks in vaccinated populations or actually accept periodic outbreaks as the cost of doing business. Publications by FDA and CDC researchers reveal these agencies’ awareness that some individuals respond poorly to mumps vaccination and that vaccine-induced antibody levels correlate poorly with protection from mumps infection, “irrespective of the number of additional doses of mumps-containing vaccine they receive.” Considering the effects on fertility, the generally abysmal track record of mumps vaccination and Merck’s fraudulent claims about efficacy, it is hard to fathom medical and public health experts’ complacency about current mumps vaccines and vaccine policies.


Sign up for free news and updates from Robert F. Kennedy, Jr. and the Children’s Health Defense. CHD is planning many strategies, including legal, in an effort to defend the health of our children and obtain justice for those already injured. Your support is essential to CHD’s successful mission.

Help Support Collective Evolution

The demand for Collective Evolution's content is bigger than ever, except ad agencies and social media keep cutting our revenues. This is making it hard for us to continue.

In order to stay truly independent, we need your help. We are not going to put up paywalls on this website, as we want to get our info out far and wide. For as little as $3 a month, you can help keep CE alive!

SUPPORT CE HERE!

cards

Continue Reading

Alternative News

Investigation Shows The MMR Vaccine Was Approved Based On Small Studies Showing Disturbing Results

Published

on

In Brief

  • The Facts:

    A FOIA request by Del Bigtree reveals that the 8 studies supporting the release of the MMR vaccine were only 6 weeks long, used only 800 children, and led to damaging respiratory and gastrointestinal illnesses to many of the children.

  • Reflect On:

    Are we ready to collectively deal with the implications of ongoing revelations of industry malfeasance with regards to vaccines that for some may require a shift in long-held beliefs?

Amidst a rash of efforts to bring forward mandatory vaccination in pockets of the United States is the recent move in New York City to declare a public health emergency Tuesday over a measles outbreak and order mandatory vaccinations in one neighborhood for people who may have been exposed to the virus.

Mayor Bill de Blasio announced the unusual order to address what he said was a measles “crisis” in Brooklyn’s Williamsburg section, where more than 250 people have gotten measles since September. The order applies to anyone living, working or going to school in four zip codes in the neighborhood. The declaration requires all unvaccinated people who may have been exposed to the virus to get the vaccine, including children over 6 months old. People who ignore the order could be fined $1,000.

Challenging Assumptions

This kind of invasive move gives rise to several serious questions, including challenging many of the assumptions that are necessarily made to justify such a move.

Assumption #1: People who may have been infected with the measles should get vaccinated immediately. De Blasio wants people who may have been infected with the measles to get vaccinated. The assumption here is that the vaccine would actually help someone who has the virus by preventing them from getting the measles or preventing them from spreading it to others. But this just doesn’t stand to reason. If someone is already infected, getting a measles vaccine will not prevent the outbreak. That’s not what a vaccine is designed for. And while the person is going through the 2-week period it takes for the vaccine to take hold, it’s quite possible that this will weaken the immune response to the actual measles infection the person has. Quarantining people suspected of being infected would be the sensible response, not vaccinating. If they happen to have the measles, no problem. Once they recover they will then be immune for life.

Assumption #2: The MMR Vaccine Can Create Herd Immunity. There is an article in the Huffington post entitled ‘I’m No Anti-Vaxxer, But the Measles Vaccine Can’t Prevent Outbreaks,’ in which Dr. Gregory Poland, who strongly advocates for vaccines, notes that outbreaks are often initiated and spread by people who have been fully vaccinated against the measles–over 50% in the case of a 2011 outbreak in Quebec. How is this possible? While this Quebec outbreak happened within a community that supposedly had achieved herd-immunity status of over 95% vaccinated, the facts are, as the article notes, that “9 per cent of children having two doses of the vaccine, as public health authorities now recommend, will have lost their immunity after just seven and a half years. As more time passes, more lose their immunity.” Therefore, herd immunity for measles is simply impossible to achieve with this vaccine.

advertisement - learn more

Assumption #3: The MMR Vaccine, in de Blasio’s words, is ‘safe, effective, and life-saving.’ The claim that the MMR vaccine is ‘life-saving’ does not stand up to simple statistics, as we detail in our article ‘Statistics Show The MMR Vaccine Kills More People Than The Measles Does.’ Whether it is effective, we have already seen that it is incapable of creating herd immunity, wanes over time, does not work at all for some people, and in some of the latest outbreaks the majority of people infected were fully vaccinated. Is it safe? This is the important question we cover in the next section.

The Studies That Stand Behind The Approval Of the MMR Vaccine

The pharmaceutical industry, as well as governmental regulatory bodies like the CDC and the FDA, assure the public that they take the safety of vaccines seriously, and that there is irrefutable science behind the notion that vaccines are safe in terms of the studies that their approval is based on.

However, a Freedom of Information Act request by Del Bigtree has revealed absolutely startling information about the studies that supported the approval of the MMR vaccines that have been injected into our children. To begin with, only 8 studies were conducted and the total combined number of children participating in the studies was only a little over 800! Furthermore, the studies only recorded symptoms for the first 6 weeks after the vaccines were given, unlike many other drug studies that follow symptoms for 5 years or more. And finally, the study revealed serious side-effects in those receiving the vaccine, including a highly significant number of participants who suffered upper respiratory illness and gastrointestinal illness, which has been linked to autism.

In our latest episode of The Collective Evolution Show on CETV, Joe, Arjun and I discussed New York’s mandatory vaccination order as well as Del Bigtree’s analysis of the MMR studies he received and the reason that Big Pharma not only does not want to do proper, large-scale studies on the safety of vaccines, but they also want to try to prevent other researchers like Dr. Christopher Exley from doing so as well.

You can watch the full episode of The Collective Evolution Show where we talk about this subject in more detail here.

You can go here to see the full episode of ‘The Highwire’ where Del Bigtree breaks down the MMR studies in question.

The Takeaway

The veils of illusion that have been masking the truth are lifting as our consciousness awakens. Transparency is coming, though how long it takes will depend on our continued efforts to dig for and spread the truth far and wide.

Help Support Collective Evolution

The demand for Collective Evolution's content is bigger than ever, except ad agencies and social media keep cutting our revenues. This is making it hard for us to continue.

In order to stay truly independent, we need your help. We are not going to put up paywalls on this website, as we want to get our info out far and wide. For as little as $3 a month, you can help keep CE alive!

SUPPORT CE HERE!

cards

Continue Reading
advertisement - learn more
advertisement - learn more

Video

Pod